Jove
Visualize
Contact Us

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retinal OCTA-derived microvascular remodeling is associated with coronary microvascular dysfunction in women with ischemia and no obstructive coronary artery disease: A pilot study.

American journal of preventive cardiology·2026
Same author

Meeting Report From the 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Amsterdam, the Netherlands, October 2025.

Pigment cell & melanoma research·2026
Same author

Choroidal metastasis of testicular choriocarcinoma: a case report and meta-analysis.

American journal of ophthalmology case reports·2026
Same author

Longitudinal Trends of Intraocular Lens Dislocation in a Federated Electronic Health Record Network.

Ophthalmic surgery, lasers & imaging retina·2026
Same author

Congenital myasthenic syndrome due to novel <i>GFPT1</i> variant presenting with head drop and visual impairment: A case report.

Journal of neuromuscular diseases·2026
Same author

Safety and Biodistribution of Topical Laquinimod, an Immunomodulator Targeting Aryl Hydrocarbon Receptor: The LION Study.

Ophthalmology science·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 24, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Unanticipated vision loss after pars plana vitrectomy.

Nieraj Jain1, Brooks W McCuen, Prithvi Mruthyunjaya

  • 1Duke University, Department of Ophthalmology, Durham, North Carolina, USA.

Survey of Ophthalmology
|February 17, 2012
PubMed
Summary

Unexplained vision loss can occur after pars plana vitrectomy despite surgical advances. This review covers retinal toxicities, vascular events, and optic neuropathies, offering prevention strategies to improve patient outcomes.

More Related Videos

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

Related Experiment Videos

Last Updated: May 24, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

Area of Science:

  • Ophthalmology
  • Retinal Surgery
  • Vision Science

Background:

  • Pars plana vitrectomy is a common intraocular surgery.
  • Despite advancements, vision loss can still occur post-surgery.
  • Understanding causes is crucial for patient safety.

Purpose of the Study:

  • To review causes of vision loss after pars plana vitrectomy.
  • To identify retinal toxicities, vascular events, and optic neuropathies.
  • To suggest strategies for prevention and limitation of vision loss.

Main Methods:

  • Literature review of post-vitrectomy vision loss.
  • Analysis of reported retinal toxicities.
  • Examination of vascular events and optic neuropathies.

Main Results:

  • Identified various causes of vision loss including iatrogenic factors.
  • Highlighted specific retinal toxicities and vascular complications.
  • Documented instances of optic nerve damage.

Conclusions:

  • Vision loss after vitrectomy can stem from diverse mechanisms.
  • Proactive identification and management of risks are essential.
  • Implementing preventative strategies can mitigate vision loss complications.